ATE468843T1 - Herstellungsverfahren für wirkstoffträgerteilchen - Google Patents

Herstellungsverfahren für wirkstoffträgerteilchen

Info

Publication number
ATE468843T1
ATE468843T1 AT05012416T AT05012416T ATE468843T1 AT E468843 T1 ATE468843 T1 AT E468843T1 AT 05012416 T AT05012416 T AT 05012416T AT 05012416 T AT05012416 T AT 05012416T AT E468843 T1 ATE468843 T1 AT E468843T1
Authority
AT
Austria
Prior art keywords
production process
carrier particles
active carrier
physiologically tolerable
production
Prior art date
Application number
AT05012416T
Other languages
English (en)
Inventor
Eva Lynenskjold
Lone Norgaard Jorgensen
Original Assignee
Alpharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Aps filed Critical Alpharma Aps
Application granted granted Critical
Publication of ATE468843T1 publication Critical patent/ATE468843T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05012416T 2000-02-17 2001-02-19 Herstellungsverfahren für wirkstoffträgerteilchen ATE468843T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0003782.0A GB0003782D0 (en) 2000-02-17 2000-02-17 Process

Publications (1)

Publication Number Publication Date
ATE468843T1 true ATE468843T1 (de) 2010-06-15

Family

ID=9885881

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01905936T ATE304843T1 (de) 2000-02-17 2001-02-19 Herstellungsverfahren für wirkstoffträgerteilchen
AT05012416T ATE468843T1 (de) 2000-02-17 2001-02-19 Herstellungsverfahren für wirkstoffträgerteilchen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01905936T ATE304843T1 (de) 2000-02-17 2001-02-19 Herstellungsverfahren für wirkstoffträgerteilchen

Country Status (9)

Country Link
US (2) US7338668B2 (de)
EP (2) EP1257256B1 (de)
AT (2) ATE304843T1 (de)
AU (1) AU784105B2 (de)
CA (1) CA2396376C (de)
DE (2) DE60113509T2 (de)
DK (2) DK1579852T3 (de)
GB (1) GB0003782D0 (de)
WO (1) WO2001060338A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8071133B2 (en) * 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040091528A1 (en) * 2002-11-12 2004-05-13 Yamanouchi Pharma Technologies, Inc. Soluble drug extended release system
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
EA011746B1 (ru) 2004-05-24 2009-06-30 Никомед Фарма Ас Агломерация кальцийсодержащего соединения прессованием на валках
US8846088B2 (en) 2005-02-03 2014-09-30 Takeda Nycomed As Melt granulation of a composition containing a calcium-containing compound
DE602006006658D1 (de) * 2005-03-04 2009-06-18 Nycomed Pharma As Verfahren zur herstellung von calciumzusammensetzungen im kontinuierlichen fliessbett
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
TR200605624A2 (tr) * 2006-10-10 2008-05-21 Nobel İlaç Sanayi̇ Ve Ti̇caret Aş. Farmasötik dozaj şekli
US9149434B2 (en) * 2007-12-03 2015-10-06 Tomita Pharmaceutical Co., Ltd. Core particle for pharmaceutical preparation
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
US20110129538A1 (en) * 2008-03-28 2011-06-02 Boehringer Ingelheim International Gmbh Process for preparing orally administered dabigatran formulations
JP2011527318A (ja) 2008-07-14 2011-10-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランを含有する医薬組成物の製造方法
ES2400210T3 (es) 2008-10-02 2013-04-08 Mylan Inc. Método para preparar un laminado de adhesivo multicapa
AU2009315729A1 (en) 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
MX2011005167A (es) * 2008-11-20 2011-05-30 Avantor Performance Mat Inc Excipiente co-procesado basado en fosfato dibasico de calcio, granular, de alta funcionalidad, directamente compresible.
US10004682B2 (en) 2010-08-24 2018-06-26 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
JP5917964B2 (ja) * 2012-03-19 2016-05-18 富士ゼロックス株式会社 錠剤、錠剤の製造方法、錠剤管理装置、錠剤照合装置及びプログラム
EP2872121B1 (de) 2012-07-12 2018-09-05 SpecGx LLC Missbrauchssichere pharmazeutische zusammensetzungen mit verzögerter freisetzung
US20220362191A1 (en) * 2021-05-12 2022-11-17 Spectrix Therapeutics, LLC Compositions and methods
EP4076501A4 (de) 2019-12-16 2024-05-08 Rutgers, the State University of New Jersey Kontinuierliche verfahren zur herstellung von imprägnierten porösen trägern und zur herstellung von arzneimitteln mit imprägnierten porösen trägern
PT3962455T (pt) 2020-05-18 2022-10-13 Orexo Ab Nova composição farmacêutica para entrega de fármacos
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833392A (en) * 1971-08-09 1974-09-03 Westinghouse Electric Corp Coating composition and method for preparing water-soluble cellulosic polymer coating compositions for coating fluorescent tubes
AU530410B2 (en) 1978-02-21 1983-07-14 Sintef Preparing aqueous emulsions
DE3064151D1 (en) * 1979-11-13 1983-08-18 Bayer Ag Coated magnetic metal or alloy pigments, process for their production, and their use
US4622057A (en) * 1983-03-02 1986-11-11 Corning Glass Works Process for making thick-walled ceramic bodies from synthetic micas
EP0439373A1 (de) * 1990-01-26 1991-07-31 Pfizer Inc. Agglomerat von niedriger Dichte unter Verwendung eines Kohlenhydrats als Bindemittel
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5397576A (en) * 1992-09-23 1995-03-14 Hoffmann-La Roche Inc. Spray triturated micronutrient compositions
JP2700141B2 (ja) * 1993-09-17 1998-01-19 富士化学工業株式会社 リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
AU697456B2 (en) * 1994-06-15 1998-10-08 Dumex-Alpharma A/S Pellets
ATE251896T1 (de) * 1994-12-19 2003-11-15 Daiichi Seiyaku Co Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
GB9519094D0 (en) * 1995-09-19 1995-11-22 Warwick Int Group Granulated active with controlled release
JP4027535B2 (ja) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末

Also Published As

Publication number Publication date
DK1257256T3 (da) 2005-12-19
AU3390001A (en) 2001-08-27
EP1257256B1 (de) 2005-09-21
US20090017125A1 (en) 2009-01-15
DE60142259D1 (de) 2010-07-08
CA2396376A1 (en) 2001-08-23
US20030211168A1 (en) 2003-11-13
EP1579852A2 (de) 2005-09-28
EP1579852B1 (de) 2010-05-26
DE60113509D1 (de) 2005-10-27
AU784105B2 (en) 2006-02-02
EP1257256A1 (de) 2002-11-20
CA2396376C (en) 2010-04-27
DK1579852T3 (da) 2010-09-27
US7338668B2 (en) 2008-03-04
EP1579852A3 (de) 2007-07-25
GB0003782D0 (en) 2000-04-05
ATE304843T1 (de) 2005-10-15
DE60113509T2 (de) 2006-06-22
WO2001060338A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
ATE468843T1 (de) Herstellungsverfahren für wirkstoffträgerteilchen
AU2002358799A8 (en) Improved structured-functional bonding matrices for biomolecules
AU4540396A (en) New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
MX260794B (es) Catalizador de metal finamente dividido y metodo de fabricarlo.
PT1180062E (pt) Metodo para a producao de micro e nanoparticulas morfologicamente uniformes utilizando micromisturadores
AU5812400A (en) Carrier-drug conjugate
ZA959386B (en) Small particle formation
AU2441995A (en) Microparticle delivery system
AU2001233543A1 (en) Carrier particles for drug delivery and process for preparation
AU2002360958A1 (en) METHOD FOR PRODUCING Beta MANNITOL DIRECTLY COMPRESSIBLE INTO TABLETS
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
AU6228699A (en) Process for producing spherical fine particles containing drug
HUP0000980A3 (en) Acrylonitrile compounds, process for their production and pesticides containing them
EP1333865A4 (de) Mit anorganischem radionuklid niedriger dichte beschichtete teilchen
AU3391400A (en) Method and apparatus for producing particle bearing filter rod
NO20001794D0 (no) Fremgangsmåte ved fremstilling av partikkelformig polymer
ZA988711B (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
PT96401A (pt) Processo de preparacao de particulas em po em particular a base de mianserina
BG104981A (en) Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
NL189581C (nl) Magnetisch registratiemateriaal, omvattende een niet-magnetische drager en een magnetische laag, die fijne en grove roetdeeltjes bevat.
DE59905726D1 (de) Rieselfähige Methionin-haltige Formlinge und Verfahren zu deren Herstellung
BR0004375A (pt) Processo para lidar com material particulado em pressão elevada
AU2003296349A8 (en) Acid activated montmorillonite based filtration aid
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
HUP0004386A3 (en) Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties